Targeted metabolomic analysis of nitric oxide/L-arginine pathway metabolites in dementia: association with pathology, severity, and structural brain changes

Intermediates of NO metabolism and dementia

As compared to control individuals, patients with dementia had significantly higher SDMA and DMA concentrations and lower ADMA, arginine-to-ADMA ratio (Arg/ADMA), L-arginine, and L-citrulline (further referred to as arginine and citrulline) (Fig. 1).

Figure 1
figure1

Intermediates of NO metabolism in patients with and without dementia: (a) arginine; (b) ADMA; (c) SDMA; (d) citrulline; (e) DMA; (f) Arg/ADMA. Data analyzed using t-test for independent samples. Geometric mean values and 95% confidence interval are given below the dot-plots and presented graphically by inverse triangles and whiskers.

Since there was significant difference in age distribution between groups, data were re-analyzed using analysis of covariance (ANCOVA) with age as a covariate. With age differences accounted for, arginine (p = 0.014 for age and p < 0.001 for dementia),…

Read more…